XML 59 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHAREHOLDERS' EQUITY (Narrative) (Details)
1 Months Ended 12 Months Ended
Feb. 22, 2021
USD ($)
$ / shares
shares
Jan. 31, 2016
$ / shares
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
$ / shares
shares
SHAREHOLDERS' EQUITY        
Aggregate gross proceeds | $     $ 0 $ 149,999,985
Share issuance transaction costs | $     $ 0 $ 9,229,450
Options granted     1,347,500 1,889,646
Weighted average fair value of options granted | $ / shares     $ 3.20 $ 8.04
Employee Share Purchase Plan [Member]        
SHAREHOLDERS' EQUITY        
Shares issued     15,820 15,963
Offering term     6 months  
Maximum eligibility to common shares amount | $     $ 25,000  
Stock Options [Member]        
SHAREHOLDERS' EQUITY        
Option expiration period     10 years  
Minimum | Employee Share Purchase Plan [Member]        
SHAREHOLDERS' EQUITY        
Price percentage of common share granted     85.00%  
Maximum | Employee Share Purchase Plan [Member]        
SHAREHOLDERS' EQUITY        
Common shares reserved for issuance     236,598 252,418
Employee contribution percentage     15.00%  
Maximum | Stock Options and RSU Plan [Member]        
SHAREHOLDERS' EQUITY        
Common shares reserved for issuance     8,410,907  
February 2021 Financing [Member]        
SHAREHOLDERS' EQUITY        
Aggregate gross proceeds | $ $ 149,999,985      
Shares issued 5,555,555      
Offering price per share | $ / shares $ 27.00      
Underwriter option to purchase additional securities 724,637      
Term of underwriters option 30 days      
Cash commissions paid | $ $ 8,999,999      
Share issuance transaction costs | $ $ 229,451      
Private Placement [Member]        
SHAREHOLDERS' EQUITY        
Shares issued   227,273    
Offering price per share | $ / shares   $ 66.00    
Units issued in private placement, conversion ratio   1    
Private Placement [Member] | 2 Year Warrants [Member]        
SHAREHOLDERS' EQUITY        
Term of warrant   2 years    
Units issued in private placement, conversion ratio   0.5    
Private Placement [Member] | 7 Year Warrants [Member]        
SHAREHOLDERS' EQUITY        
Term of warrant   7 years    
Units issued in private placement, conversion ratio   1    
Private Placement [Member] | Clarus Lifesciences III, L.P [Member]        
SHAREHOLDERS' EQUITY        
Shares issued   106,061    
Minimum number of shares required to be held for nomination rights   53,030